Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the condition when steroids or surgery fail, by targeting the inflammatory cascade that drives their growth. Nasal polyps are benign growths on the inside of […]
asthma
Rhinovirus vaccine development is about more than fighting colds
Rhinovirus, the pathogen behind the common cold, can cause severe, acute lung disease in children and those with underlying respiratory conditions. Since the 1970s, vaccine development has been hindered by the presence of numerous virus serotypes and the lack of a good animal model to test vaccine candidates. However, several different research groups are now […]